MYC and neoplasm: The pharmacological compounds DHE and ALP are sufficient to block AML tumor growth by inducing Nr4a expression and down regulating c-Myc [75] Nr4a3 overexpression decreased SuDHL4 B cell line proliferation and xenograph growth.